PREDICTORS OF RECURRENCE IN SURGICALLY STAGED INTERMEDIATE-RISK EARLY-STAGE CERVICAL CANCER

被引：0
|
作者：
Artuso, Valeria [1 ]
Meschini, Tommaso [1 ]
Schivardi, Gabriella [2 ]
Antonio De Vitis, Luigi [3 ]
Multinu, Francesco [2 ]
Martin-Calvo, Nerea [4 ]
Chiva, Luis [5 ]
Ghezzi, Fabio [1 ]
Casarin, Jvan [1 ]
机构：
[1] Univ Insubria, Womens & Childrens Ponte Hosp, Dept Obstet & Gynecol, Varese, Italy
[2] IRCCS European Inst Oncol, Dept Gynecol Surg, Milan, Italy
[3] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA
[4] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain
[5] Clin Univ Navarra, Dept Obstet & Gynecol, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
666
引用
下载
收藏
页码：A87 / A88
页数：2
相关论文
共 50 条
  • [1] Adenocarcinoma as an independent risk factor for early-stage intermediate-risk cervical carcinoma
    Mathews, C.
    Goodrich, S.
    Farrell, R.
    DeSimone, C.
    Seamon, L.
    Landrum, L.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S104 - S105
  • [2] Management of patients with intermediate-risk early stage cervical cancer
    Cibula, David
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (03)
  • [3] Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
    Matsuo, Koji
    Shimada, Muneaki
    Matsuzaki, Shinya
    Machida, Hiroko
    Shigeta, Shogo
    Yoshida, Hiroshi
    Kato, Kazuyoshi
    Kanao, Hiroyuki
    Takekuma, Munetaka
    Mikami, Mikio
    Okamoto, Aiko
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [4] A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors
    Fu, Chunli
    Wang, Cong
    Qian, Qiuhong
    Zhang, Youzhong
    Ma, Changdong
    Miao, Li
    Zhang, Guangyu
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 48
  • [5] Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer
    Cao, Lijie
    Wen, Hao
    Feng, Zheng
    Han, Xiaotian
    Zhu, Jun
    Wu, Xiaohua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 52 - 58
  • [6] A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.
    Zhang, Guangyu
    Fu, Chunli
    Ma, Changdong
    Zhang, Youzhong
    Miao, Li
    Wang, Cong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17521 - E17521
  • [7] The baseline recurrence risk of patients with intermediate-risk cervical cancer
    Yoneoka, Yutaka
    Kato, Mayumi Kobayashi
    Tanase, Yasuhito
    Uno, Masaya
    Ishikawa, Mitsuya
    Murakami, Takashi
    Kato, Tomoyasu
    OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (02) : 226 - 233
  • [8] Impact of preoperative leukocyte alteration in surgically-treated early-stage cervical cancer patients with low-risk, intermediate-risk or high-risk factors
    Matsumoto, Y.
    Mabuchi, S.
    Kozasa, K.
    Kuroda, H.
    Sasano, T.
    Yokoi, E.
    Sawada, K.
    Kimura, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 939 - 946
  • [9] Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer
    Chatterjee, Sudeshna
    Chen, Ling
    Tergas, Ana I.
    Burke, William M.
    Hou, June Y.
    Hu, Jim C.
    Ananth, Cande V.
    Neugut, Alfred I.
    Hershman, Dawn L.
    Wright, Jason D.
    OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 992 - 1002
  • [10] Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm
    Chu, Ran
    Zhang, Yue
    Qiao, Xu
    Xie, Lin
    Chen, Wei
    Zhao, Ying
    Xu, Yintao
    Yuan, Zeng
    Liu, Xiaolin
    Yin, Aijun
    Wang, Zhiwen
    Zhang, Qing
    Yang, Xingsheng
    Su, Xuantao
    Kong, Beihua
    Song, Kun
    ONCOLOGIST, 2021, 26 (12): : E2217 - E2226
12345